JP2007504463A - 卵巣癌用の診断マーカー - Google Patents

卵巣癌用の診断マーカー Download PDF

Info

Publication number
JP2007504463A
JP2007504463A JP2006525571A JP2006525571A JP2007504463A JP 2007504463 A JP2007504463 A JP 2007504463A JP 2006525571 A JP2006525571 A JP 2006525571A JP 2006525571 A JP2006525571 A JP 2006525571A JP 2007504463 A JP2007504463 A JP 2007504463A
Authority
JP
Japan
Prior art keywords
haptoglobin
ovarian cancer
precursor
antibody
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006525571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504463A5 (enExample
Inventor
ヌハト アーメッド
グレゴリー エドワード ライス
マイケル アンソニー シン
Original Assignee
ロイヤル ウィメンズ ホスピタル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904844A external-priority patent/AU2003904844A0/en
Application filed by ロイヤル ウィメンズ ホスピタル filed Critical ロイヤル ウィメンズ ホスピタル
Publication of JP2007504463A publication Critical patent/JP2007504463A/ja
Publication of JP2007504463A5 publication Critical patent/JP2007504463A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006525571A 2003-09-05 2004-09-06 卵巣癌用の診断マーカー Pending JP2007504463A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003904844A AU2003904844A0 (en) 2003-09-05 Diagnostic marker
PCT/AU2004/001205 WO2005024054A1 (en) 2003-09-05 2004-09-06 Diagnostic marker for ovarian cancer

Publications (2)

Publication Number Publication Date
JP2007504463A true JP2007504463A (ja) 2007-03-01
JP2007504463A5 JP2007504463A5 (enExample) 2007-05-31

Family

ID=34230078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006525571A Pending JP2007504463A (ja) 2003-09-05 2004-09-06 卵巣癌用の診断マーカー

Country Status (6)

Country Link
US (1) US20070053896A1 (enExample)
EP (1) EP1668149A4 (enExample)
JP (1) JP2007504463A (enExample)
CN (1) CN1871362A (enExample)
CA (1) CA2537955A1 (enExample)
WO (1) WO2005024054A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010066225A (ja) * 2008-09-12 2010-03-25 Nagoya Univ 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー
WO2011162563A3 (ko) * 2010-06-24 2012-05-31 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
WO2017170597A1 (ja) * 2016-03-29 2017-10-05 協和発酵キリン株式会社 血中でハプトグロビンに結合して多価の免疫複合体を形成する抗体を有効成分とする自己免疫疾患治療剤

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
CN101243319B (zh) 2005-06-22 2016-01-06 约翰·霍普金斯大学 卵巢癌的生物标记：ctap3-相关蛋白质
JP5237817B2 (ja) * 2005-10-21 2013-07-17 ジーンニュース インコーポレーティッド バイオマーカー産物レベルを疾患に相関させるための方法および装置
EP2363205A3 (en) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
EP1987360B1 (en) * 2006-01-27 2012-03-07 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530168B1 (en) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Microfluidic Devices
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
SG140505A1 (en) * 2006-09-05 2008-03-28 Univ Singapore Diagnostic biomolecule(s)
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
GB0917044D0 (en) * 2009-09-29 2009-11-18 Cytoguide As Agents, uses and methods
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
WO2011143292A1 (en) * 2010-05-11 2011-11-17 Ohio University Biomarkers for detecting erythropoietin use in human subjects
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (en) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
EP2675819B1 (en) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
WO2012174569A2 (en) * 2011-06-17 2012-12-20 The Board Of Trustees Of The University Of Arkansas New markers for early diagnosis of ovarian cancer, monitoring during therapy, and new therapy options during and after chematherapy
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
CN104225619B (zh) * 2013-06-09 2018-04-17 上海吉凯基因化学技术有限公司 人ilk基因治疗肿瘤的用途及其相关药物
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
KR101582416B1 (ko) * 2014-06-30 2016-01-06 가톨릭대학교 산학협력단 프로합토글로빈을 이용한 간암 진단방법
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN106520924A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测卵巢癌的引物组及检测方法
CN106544421B (zh) * 2016-10-21 2020-05-08 武汉科技大学 Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN114324557B (zh) * 2021-12-03 2024-05-10 融智生物科技（青岛）有限公司 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946774A (en) * 1987-11-09 1990-08-07 Trustees Of Boston University Process for detecting cancer and for monitoring the effectiveness of cancer therapy
KR0174528B1 (ko) * 1989-01-17 1999-05-15 마이클 이. 존스 암과 관련된 헵토글로빈
GB9805477D0 (en) * 1998-03-13 1998-05-13 Oxford Glycosciences Limited Methods and compositions for diagnosis of rheumatoid arthritis
US7112408B2 (en) * 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
AU2002335963A1 (en) * 2001-11-23 2003-06-10 Syn.X Pharma, Inc. Protein biopolymer markers predictive of alzheimers disease
AU2003235749A1 (en) * 2002-01-07 2003-07-24 John Hopkins University Biomarkers for detecting ovarian cancer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010066225A (ja) * 2008-09-12 2010-03-25 Nagoya Univ 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー
WO2011162563A3 (ko) * 2010-06-24 2012-05-31 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
WO2017170597A1 (ja) * 2016-03-29 2017-10-05 協和発酵キリン株式会社 血中でハプトグロビンに結合して多価の免疫複合体を形成する抗体を有効成分とする自己免疫疾患治療剤

Also Published As

Publication number Publication date
EP1668149A4 (en) 2007-01-03
WO2005024054A1 (en) 2005-03-17
CA2537955A1 (en) 2005-03-17
CN1871362A (zh) 2006-11-29
US20070053896A1 (en) 2007-03-08
EP1668149A1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
US20070053896A1 (en) Diagnostic marker for ovarian cancer
JP5006802B2 (ja) 上皮由来の癌診断および予後診断のためのバイオマーカーとしてのＣｙｒ６１
Ye et al. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine
US8911951B2 (en) Plasma kallikrein fragments as diagnostic biomarkers for lung cancers
US20190361028A1 (en) Free ngal as a biomarker for cancer
CN103547923B (zh) 乳腺癌的生物标记
US20090209431A1 (en) Non-Invasive in Vitro Method to Detect Transitional Cell Carcinoma of the Bladder
US20100240088A1 (en) Peptide Markers for Diagnosis of Angiogenesis
CA2625403A1 (en) Tissue-and serum-derived glycoproteins and methods of their use
US7211397B2 (en) Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
WO2010015659A1 (en) Cancer markers and methods for their detection
JP4847873B2 (ja) 上皮起源の癌を診断および予後診断するための方法
US8642347B2 (en) Urinary CA125 peptides as biomarkers of ovarian cancer
Gibson et al. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis
Kamada et al. Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma
CN109517049B (zh) Linc00266-1多肽作为实体瘤标志物的应用
WO2019242741A1 (en) Biomarkers for urothelial carcinoma and applications thereof
WO2009034562A2 (en) A method of assessing lung squamous cell carcinoma status in an individual
US20150219660A1 (en) Biomarkers for the diagnosis and/or prognosis of clear cell renal cell carcinoma
AU2004270759A1 (en) Diagnostic marker for ovarian cancer
KR20190068853A (ko) 갑상선암 진단용 조성물 및 상기 조성물을 이용한 갑상선암 진단 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070323